
FONAR Corporation FONR
$ 18.55
0.27%
Quarterly report 2025-Q4
added 02-13-2026
FONAR Corporation DSO Ratio 2011-2026 | FONR
Annual DSO Ratio FONAR Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 237 | 221 | 200 | 189 | 170 | 164 | 157 | 200 | 106 | 114 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 237 | 106 | 176 |
Quarterly DSO Ratio FONAR Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.7 | 17.1 | 13.4 | 13.3 | 13.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | 35.2 | 3.37 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.9 | 24.9 | 26.9 | 25.7 | 23 | 25.4 | 46.6 | 48 | 48.4 | 47.6 | 46.6 | 47.3 | 51.5 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.37 K | 11.9 | 198 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 39.26 | -0.03 % | $ 5.85 K | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
72 | $ 8.01 | 2.43 % | $ 575 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 9.63 | 2.39 % | $ 1.3 B | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 4.17 | 4.51 % | $ 155 M | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 43.47 | 0.36 % | $ 1.35 B | ||
|
Electromed
ELMD
|
137 | $ 24.2 | 0.92 % | $ 205 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
40.7 | $ 29.57 | -0.87 % | $ 1.36 B | ||
|
Apyx Medical Corporation
APYX
|
85.8 | $ 3.22 | 1.58 % | $ 111 M | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Accuray Incorporated
ARAY
|
69.7 | $ 0.52 | -1.73 % | $ 53.4 M | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Medigus Ltd.
MDGS
|
29.4 | - | 10.28 % | $ 55.5 M | ||
|
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.79 | -1.52 % | $ 43 M | ||
|
Align Technology
ALGN
|
86.7 | $ 183.62 | 0.54 % | $ 13.7 B | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Inari Medical
NARI
|
48 | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
76.1 | $ 3.94 | 6.35 % | $ 834 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
61.2 | $ 113.39 | -0.17 % | $ 197 B | ||
|
NuVasive
NUVA
|
70.4 | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
67.6 | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 72.39 | -1.98 % | $ 107 B | ||
|
InMode Ltd.
INMD
|
5.36 | $ 13.53 | -0.51 % | $ 874 M | ||
|
Helius Medical Technologies
HSDT
|
53.3 | $ 2.14 | 8.08 % | $ 1.3 M | ||
|
Alphatec Holdings
ATEC
|
43.1 | $ 12.99 | -0.23 % | $ 1.95 B | ||
|
IRIDEX Corporation
IRIX
|
45.6 | $ 1.42 | -0.7 % | $ 22.9 M | ||
|
IRadimed Corporation
IRMD
|
56.8 | $ 105.43 | 1.09 % | $ 1.34 B | ||
|
Edwards Lifesciences Corporation
EW
|
38.2 | $ 85.35 | 0.1 % | $ 49.9 B |